Birmingham, AL 35294-4460
United States
University of Alabama at Birmingham
Clinical trials, Lung cancer, Bispecific Antibodies, Antibody Drug Conjugates, ADC, BsAb.
Non-small cell lung cancer, PD-L1 negative, Immune Checkpoint Inhibitors, Circulating tumor DNA, Chemotherapy